Epoch Investment Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-76,608
Closed -$8M 331
2017
Q4
$8M Sell
76,608
-19,718
-20% -$2.22M 0.03% 228
2017
Q3
$14M Buy
96,326
+21,433
+29% +$2.92M 0.05% 213
2017
Q2
$9.73M Buy
74,893
+48,573
+185% +$5.95M 0.03% 223
2017
Q1
$3.27M Hold
26,320
0.01% 262
2016
Q4
$3.05M Buy
26,320
+7,904
+43% +$880K 0.01% 231
2016
Q3
$1.93M Buy
18,416
+4,107
+29% +$444K 0.01% 244
2016
Q2
$1.41M Sell
14,309
-1,141
-7% -$118K 0.01% 248
2016
Q1
$1.55M Sell
15,450
-3
-0% -$309 0.01% 235
2015
Q4
$1.85M Buy
+15,453
New +$1.79M 0.01% 226

Other funds holding CELG

Epoch Investment Partners's CELG Position: Q1 2018 in Review

Epoch Investment Partners sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 76,608 shares — an estimated $8M sold.

Epoch Investment Partners first reported a position in CELG in Q4 2015 and held it in 9 quarters. The position peaked at $14M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Epoch Investment Partners reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Epoch Investment Partners sold 76,608 Celgene Corp shares in Q1 2018, an estimated $8M.
  • Epoch Investment Partners first reported a position in Celgene Corp in Q4 2015 and held it in 9 quarters.
  • Epoch Investment Partners's Celgene Corp position peaked at $14M in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Epoch Investment Partners's 13F filing for Q1 2018, filed 14 May 2018.